Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mange Ram Yadav

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Pharmaceutical Patent Analyst|August 2, 2018
Advances in patented CB1 receptor antagonists for obesityMange Ram Yadav, Prashant R Murumkar
Bioorganic & Medicinal Chemistry Letters|February 4, 2006
3D-QSAR studies of farnesyltransferase inhibitors: a comparative molecular field analysis approachDevendra Puntambekar, Rajani Giridhar, Mange Ram Yadav
International Journal of Pharmaceutics|December 19, 2006
Bismuth-norfloxacin complex: synthesis, physicochemical and antimicrobial evaluationAnwar R Shaikh, Rajani Giridhar, Mange Ram Yadav
European Journal of Medicinal Chemistry|April 24, 2007
Insights into the structural requirements of farnesyltransferase inhibitors as potential anti-tumor agents based on 3D-QSAR CoMFA and CoMSIA modelsDevendra S Puntambekar, Rajani Giridhar, Mange Ram Yadav
Expert Opinion on Drug Discovery|December 13, 2012
Novel methods and strategies in the discovery of TACE inhibitorsPrashant R Murumkar, Rajani Giridhar, Mange Ram Yadav
Acta Pharmaceutica (Zagreb, Croatia)|April 15, 2006
3D-QSAR CoMFA/CoMSIA studies on 5-aryl-2,2-dialkyl-4-phenyl-3(2H)-furanone derivatives, as selective COX-2 inhibitorsDevendra Sharad Puntambekar, Rajani Giridhar, Mange Ram Yadav
Chemical Biology & Drug Design|February 21, 2008
3D-quantitative structure-activity relationship studies on benzothiadiazepine hydroxamates as inhibitors of tumor necrosis factor-alpha converting enzymePrashant R Murumkar, Rajani Giridhar, Mange Ram Yadav
Journal of Enzyme Inhibition and Medicinal Chemistry|May 24, 2007
Inhibition of farnesyltransferase: a rational approach to treat cancer?Devendra S Puntambekar, Rajani Giridhar, Mange Ram Yadav
ACS Omega|December 20, 2021
Further Studies on Cationic Gemini Amphiphiles as Carriers for Gene Delivery-The Effect of Linkers in the Structure and Other Factors Affecting the Transfection Efficacy of These AmphiphilesMange Ram Yadav, Mukesh Kumar, Prashant R Murumkar
Bioorganic & Medicinal Chemistry|November 13, 2010
Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists--a perspectivePrashant Naik, Prashant Murumkar, Rajani Giridhar, et al.
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Pharmaceutical Patent Analyst|August 2, 2018
Advances in patented CB1 receptor antagonists for obesityMange Ram Yadav, Prashant R Murumkar
Bioorganic & Medicinal Chemistry Letters|February 4, 2006
3D-QSAR studies of farnesyltransferase inhibitors: a comparative molecular field analysis approachDevendra Puntambekar, Rajani Giridhar, Mange Ram Yadav
International Journal of Pharmaceutics|December 19, 2006
Bismuth-norfloxacin complex: synthesis, physicochemical and antimicrobial evaluationAnwar R Shaikh, Rajani Giridhar, Mange Ram Yadav
European Journal of Medicinal Chemistry|April 24, 2007
Insights into the structural requirements of farnesyltransferase inhibitors as potential anti-tumor agents based on 3D-QSAR CoMFA and CoMSIA modelsDevendra S Puntambekar, Rajani Giridhar, Mange Ram Yadav
Expert Opinion on Drug Discovery|December 13, 2012
Novel methods and strategies in the discovery of TACE inhibitorsPrashant R Murumkar, Rajani Giridhar, Mange Ram Yadav
Acta Pharmaceutica (Zagreb, Croatia)|April 15, 2006
3D-QSAR CoMFA/CoMSIA studies on 5-aryl-2,2-dialkyl-4-phenyl-3(2H)-furanone derivatives, as selective COX-2 inhibitorsDevendra Sharad Puntambekar, Rajani Giridhar, Mange Ram Yadav
Chemical Biology & Drug Design|February 21, 2008
3D-quantitative structure-activity relationship studies on benzothiadiazepine hydroxamates as inhibitors of tumor necrosis factor-alpha converting enzymePrashant R Murumkar, Rajani Giridhar, Mange Ram Yadav
Journal of Enzyme Inhibition and Medicinal Chemistry|May 24, 2007
Inhibition of farnesyltransferase: a rational approach to treat cancer?Devendra S Puntambekar, Rajani Giridhar, Mange Ram Yadav
ACS Omega|December 20, 2021
Further Studies on Cationic Gemini Amphiphiles as Carriers for Gene Delivery-The Effect of Linkers in the Structure and Other Factors Affecting the Transfection Efficacy of These AmphiphilesMange Ram Yadav, Mukesh Kumar, Prashant R Murumkar
Bioorganic & Medicinal Chemistry|November 13, 2010
Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists--a perspectivePrashant Naik, Prashant Murumkar, Rajani Giridhar, et al.
Pageof 9